All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.
To help navigate the exciting content being presented at ASH2021, the MDS Hub Steering Committee members have provided their recommendations for the top abstracts to look out for in MDS, in 2 categories: novel treatment combinations and practice-changing abstracts.
ASH21 abstracts: What’s hot in MDS?
If you would like to view the top abstracts for myelodysplastic syndromes from ASH21, please download the resource below.Download here
What new developments are there in the treatment of relapsed or refractory MDS?
During the 63rd ASH Annual Meeting and Exposition, the MDS Hub was pleased to speak to Amer Zeidan, Yale School of Medicine, New Haven, US. We asked, What new...
How successful is CPX-351 as first-line treatment for MDS?
During the 63rd ASH Annual Meeting and Exposition, the MDS Hub was pleased to speak to Pierre Fenaux, CHU de Nantes, Nantes, FR. We asked, How successful is CPX-351 as first-line treatment...
Subscribe to get the best content related to MDS delivered to your inbox